Company Filing History:
1 out of 96 
1 out of 1 Years Active: 2017
Title: Young-Bong Kim: Innovator in Baculovirus-based Vaccines
Introduction
Young-Bong Kim is a notable inventor based in Goyang-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work focuses on utilizing recombinant baculoviruses to enhance immune responses.
Latest Patents
Young-Bong Kim holds a patent for a recombinant baculovirus that comprises a nucleotide sequence encoding a foreign virus envelope protein, a first promoter linked to the envelope-encoding sequence, a nucleotide sequence encoding an antigen protein, and a second promoter linked to the antigen-encoding sequence. This invention relates to a vaccine composition that demonstrates excellent efficacy in both humoral and cellular immune responses against specific antigens, such as HPV L1. This advancement enables the baculovirus to function as a more efficient DNA vaccine.
Career Highlights
Throughout his career, Young-Bong Kim has worked with various organizations, including Konkuk University Industrial Cooperation Corporation and Kr Biotech Co., Ltd. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Hee Jung Lee and Nuri Park. Their collaborative efforts have furthered the development of innovative solutions in biotechnology.
Conclusion
Young-Bong Kim's work in baculovirus-based vaccines represents a significant advancement in vaccine technology. His contributions are paving the way for more effective immunization strategies.